查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
到 2028 年的皮内註射市场预测-COVID-19 的影响和方法、应用和最终用户的全球分析
市场调查报告书
商品编码
1126276

到 2028 年的皮内註射市场预测-COVID-19 的影响和方法、应用和最终用户的全球分析

Intradermal injection Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Method, Application, and End User
出版日期: | 出版商: The Insight Partners | 英文 197 Pages | 订单完成后即时交付

价格

皮内註射市场预计将从 2021 年的 35.1326 亿美元增至 2028 年的 74.157 亿美元，2021 年至 2028 年的复合年增长率为 11.3%。

本报告涵盖了市场上普遍存在的趋势以及推动市场增长的因素。皮内註射市场的增长归因于皮内疫苗接种的增加、各种疾病的发病率增加以及整容手术的接受度不断提高。此外，製造商的战略发展预计将成为预测期内市场的主要趋势。然而，与皮内註射相关的风险、并发症和剂量限制阻碍了皮内註射市场的增长。

许多发展中国家和发达国家现在将医疗保健行业视为其关键领域之一，医疗保健成本呈指数级增长，旨在提供更好的基础设施和医疗设施。带来各种製药公司都在努力开发理想的药物和设备，以满足日益增长的全球需求，而皮内註射是用于治疗、诊断、疫苗接种、整容手术等的潜在设备之一。皮内接种的日益普及被认为是全球皮内註射市场的主要驱动因素，因为它提供了优于传统接种方法的几个优势。皮内接种可减少抗原的潜在剂量，改善疫苗产生的免疫反应，并有助于减少与疫苗接种相关的焦虑。皮内接种的发展使得大量人群能够以相对较小的疫苗生产量接种疫苗，并且与常规接种疫苗和难以共病的人群相比，不良事件发生的可能性也更低，接种疫苗也是可能的。近年来，COVID19、甲肝疫苗、乙肝疫苗、流感疫苗、脊髓灰质炎疫苗、麻疹疫苗、狂犬病疫苗、破伤风疫苗、黄热病疫苗、白喉/破伤风/百日咳疫苗等皮内疫苗已经普及。为了提高反应率，几家主要的製药和生物技术公司正在努力开发新型皮内给药以及商业疫苗。 2020 年，Sanofi获得了 FDA 批准的皮内疫苗 Fluzone，该疫苗正迅速超越流感疫苗市场，并有望取代这些疾病的先天性治疗。

世界上超过三分之一的人口也有患肺结核的风险，过去几年进行的肺结核皮肤测试数量急剧增加。皮内结核菌素注射器用于诊断结核病，目前由几家主要的药物输送设备製造商开发。与此同时，在过去十年中，过敏症的患病率增加了几倍。这主要是由于公众对几种过敏相关疾病的认识有所提高。皮内註射已被用作对几种过敏原进行敏感性测试的理想设备。

除此之外，局部整容手术也在迅速增长，据 ISAPS 估计，从 2011 年到 2017 年，非手术整容手术的数量增加了 51.4%。与此同时，据信许多新的皮内註射剂将获得批准，因为皮内註射剂可以提供更好的反应，减少剂量要求和不良事件。研究还表明，皮内给药可提高抗癌药物和免疫剂的吸收，可用于给药基因治疗药物。此外，COVID19 病例的持续增加也表明了该领域的未来潜力。随着世界人口的增加，预计在不久的将来患者人数将增加，皮内註射的需求预计也会增加。此外，PharmaJet 的 Tropis ID 等新型皮内给药装置在输送针对各种疾病的药物方面表现出卓越的功效，从而扩大了皮内产品的治疗范围。

除了皮内註射的优点外，这些给药装置也存在一些缺点，如注射部位反应和剂量限制等，这些都是製约皮内註射市场的主要因素。在皮内施用活性成分后，观察到注射部位皮肤的变色、肿胀、发红、瘙痒和炎症。为了克服与註射部位感染相关的挑战，研究人员正在努力确定注射药物的理想部位，具体取决于药物的性质和所需的作用。

在过去的几年中，皮内註射相关的程序和设备不断创新，并为该领域的发展引入了多项新技术。在过去十年中，与多种并发症相关的疫苗接种和诊断率呈指数增长，最终增加了皮内註射的接受度。

公司在皮内註射市场采用了几种有机和无机策略。有机战略主要包括产品发布和产品批准。此外，皮内註射市场的无机增长战略是收购、合作和伙伴关係。这些增长战略使市场参与者能够扩大业务并增强其地域影响力，从而促进皮内註射市场的整体增长。此外，收购和合作战略有助于市场参与者加强其客户群并扩大其产品组合。下面列出了皮内註射市场主要参与者的一些显着发展。

2021 年 11 月，NanoPass Technologies 和Aesthetic Management Partners达成协议，开始在美国将 NanoPass 的 MicronJet 600 皮内给药装置商业化。

2021 年 8 月，PharmaJet 和 Zydus Cadila 获得了印度药品管理局 (DCGI) 的 ZyCoV-D 紧急使用授权 (EUA)，ZyCoV-D 是世界上第一个用于 COVID-19 的质粒 DNA 疫苗。 ZyCoV-D 是一种使用 PharmaJet Tropis 无针注射系统的单次给药疫苗。

在准备皮内註射剂市场报告时，世界卫生组织 (WHO)、疾病控制和预防中心 (CDC)、国民健康保险等被引用为主要和次要信息。

内容

第一章介绍

  • 调查范围
  • Insight Partners 研究报告指南
  • 市场细分
    • 全球皮内註射剂市场-按方法
    • 全球皮内註射剂市场-按应用
    • 全球皮内註射剂市场 - 按最终用户分类
    • 全球皮内註射剂市场 - 按地区

第 2 章. 要点

第三章研究方法

  • 范围
  • 二次调查
  • 初步调查

第四章皮内註射市场情况

  • PEST 分析
    • 北美 - PEST 分析
    • 欧洲 - PEST 分析
    • 亚太地区的 PEST 分析
    • 中东和非洲的 PEST 分析
    • 拉丁美洲 - PEST 分析
  • 专家意见

第 5 章皮内註射剂市场 - 主要市场动态

  • 主要市场驱动因素
    • 增加皮内接种
    • 发病率增加
    • 对整容手术的接受度提高
  • 主要市场製约因素
    • 与皮内註射相关的风险、并发症和剂量限制
  • 主要市场机会
    • 发达国家和发展中国家的显着增长机会
  • 未来趋势
    • 製造商的战略发展
  • 驱动因素和製约因素的影响分析

第 6 章全球皮内註射剂市场 - 分析

  • 皮下注射剂全球市场收入、预测与分析
  • 全球皮下注射剂市场：按地区划分的预测和分析
  • 主要参与者的市场定位

第 7 章：皮内註射剂全球市场收入和到 2028 年的预测 - 按方法分类

  • 2021 年和 2028 年按方法分列的全球皮内註射剂市场 (%)
  • 普通尺寸的针（MANTOUX）
  • 短针
  • 无针

第 8 章全球皮下注射剂市场收入和到 2028 年的预测 - 应用

  • 2021 年和 2028 年按应用分列的皮内註射剂全球市场份额 (%)
  • 结核菌素皮肤反应
  • 过敏测试
  • 局部美容
  • 其他
    • 其他市场展望与分析

第 9 章皮内註射剂市场分析 - 最终用户

  • 2021 年和 2028 年全球皮内註射剂市场：按最终用户分类（%）
  • 医院
  • 诊断实验室
  • 学术和研究机构
  • 其他

第 10 章皮内註射剂市场收入和到 2028 年的预测 - 区域分析

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲
    • 阿联酋
    • 沙特阿拉伯
    • 南非
    • 其他中东和非洲
  • 中美洲和南美洲
    • 中美洲和南美洲
      • 阿根廷
      • 巴西
      • 其他拉丁美洲

第 11 章 COVID-19 大流行对皮内註射市场的影响

  • 北美
  • 欧洲
  • 亚太地区
  • 中东和非洲
  • 拉丁美洲

第 12 章皮内註射剂市场 - 行业格局

  • 市场概览
  • 发展状况

第 13 章公司简介

  • BD
  • West Pharmaceutical Services, Inc.
  • Terumo Corporation
  • NanoPass
  • Pharmajet
  • Idevax
  • EUNSUNG GLOBAL
  • Crossject
  • Cardinal Health Inc.
  • Hindustan Syringes and Medical Devices Ltd

第十四章附录

  • 关于 The Insight Partners
  • 词彙表
Product Code: TIPRE00019998

The intradermal injection market is projected to reach US$ 7,415.70 million by 2028 from US$ 3,513.26 million in 2021 and is expected to register a CAGR of 11.3% from 2021 to 2028.

The report highlights trends prevailing in the market and factors driving the market growth. The intradermal injection market growth is attributed to the increasing intradermal vaccination, increasing incidence of various diseases, and rising acceptance of aesthetic procedures. Additionally, stratageic developments by manufacturers are likely to emerge as a significant trend in the market during the forecast period. However, the risks, complications, and dosing limitations associated with Intradermal Injections hamper the growth of the intradermal injection market.

Most of the developing and developed countries are currently considering the healthcare sector as one of the essential segments, which resulted in the exponential increase in healthcare expenditure with the aim of providing better infrastructure and medical facilities. For fulfilling the rising global demand, various pharmaceutical giants are working to develop ideal drugs and devices, and intradermal injections are emerging as one of the potential devices used for the treatment, diagnosis, vaccination, and cosmetic procedures. Rising acceptance of intradermal vaccination is believed to act as major driver for the global intradermal injection market as it has several advantages over the conventional method of vaccination. Intradermal vaccination helps in reducing the potential dose of antigens, improves the immune response generated by the vaccine and decrease the anxiety associated with the vaccination. By developing intradermal injection, a large population can be vaccinated with comparatively lesser production of the vaccine while this method is also able to vaccinate the difficult group of population with comorbidities as chances of adverse events is low as compared to conventional vaccination. Recently, several intradermal COVID19 vaccines, hepatitis A vaccine, hepatitis B vaccine, Influenza vaccines, polio vaccine measles vaccine, Rabies vaccine, tetanus vaccine, yellow fever vaccine, diphtheria-tetanus-pertussis vaccine etc. shows improvement in the overall response rate and hence several leading pharmaceutical and biotechnological companies are currently working on the development of intradermal injections of the new as well as commercially available vaccines. In 2020, Sanofi received the FDA approval for its intradermal vaccine of Influenza names Fluzone, which is rapidly overtaking the influenza vaccine market and replacing the congenital treatments for these diseases.

Further, more than one-third of the global population has a risk of developing tuberculosis, and an intense increase in the number of tuberculosis skin test procedures has been observed during the past few years. Intradermal tuberculin syringes are used for diagnosing tuberculosis, and several leading manufacturers of drug delivery devices are currently developing these tuberculin syringes. Along with this, the prevalence of allergies has increased several times during the past decade, mainly due to the rise in awareness among the population about several allergy-related conditions. The intradermal injections are used as an ideal device for conducting sensitivity tests for several allergens.

In addition to this, the local aesthetic procedures are also increasing rapidly, and the number of nonsurgical cosmetic procedures has increased by 51.4% from 2011 to 2017 as per the estimates of ISAPS. Along with this, many new intradermal vaccinations are believed to get approval as intradermal vaccination is able to produce better response along with reduction in the required dose and adverse events. . Along with this, several studies concluded that the intradermal injection could improve the uptake of various cancers and immunological drugs while it can also be used to deliver the gene therapies. Further, continuously increasing cases of COVID19 is also indicating towards the future potential of this segment as various intradermal preparations are under investigation and about to get approved in near future. As the global population is increasing continuously, the number of cases will also increase in near future, which ultimately increases the demand of intradermal injection. Further, the novel intradermal injection devices such as Tropis ID of Pharmajet shows prominent results in delivering various drugs for targeting a wide range of diseases and expands the therapeutic area of the intradermal products.

Besides the benefits of intradermal injection, several drawbacks are also associated with these drug delivery devices including injection site reactions and dosing limitations, which are acting as major restraints for the intradermal injection market. It is observed that skin discoloration, swelling, redness, itching and irritation occurs at the site of injection after the intradermal delivery of active ingredient. For overcoming the challenges related to the injection site infections, the researchers are working to identify ideal site for injecting the drug depending upon the nature of drug and required action.

During the past few years, intradermal injections associated procedures and devices have undergone continuous innovations, and several novel technologies are incorporated in this segment for the advancement of this sector. The vaccination and diagnosis rates related to several complications have increased exponentially during the last decade, ultimately increasing the acceptance of intradermal injections.

Several organic and inorganic strategies are adopted by companies in the intradermal injection market. The organic strategies mainly include product launches and product approvals. Further, inorganic growth strategies witnessed in the intradermal injection market are acquisitions, collaborations, and partnerships. These growth strategies allow the market players to expand their businesses and augment their geographic presence, thereby contributing to the overall growth of intradermal injection market. Further, acquisition and partnership strategies help the market players strengthen their customer base and expand their product portfolios. A few of the noteworthy developments by key players in the intradermal injection market are listed below.

In November 2021, NanoPass Technologies and Aesthetic Management Partners entered into an agreement to initiate the commercialization of NanoPass's MicronJet 600 intradermal delivery device in the US.

In August 2021, PharmaJet and Zydus Cadila received the Emergency Use Authorization (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D, the world's first Plasmid DNA Vaccine for COVID-19. The vaccine, ZyCoV-D, is solely administered utilizing the PharmaJet Tropis Needle-free Injection System.

The World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), and National Health and Wellness are among the primary and secondary sources referred while preparing the report on the intradermal injection market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Intradermal Injection market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global Intradermal Injection market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distributions.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Intradermal Injections Market - By Method
    • 1.3.2 Global Intradermal Injections Market - By Application
    • 1.3.3 Global Intradermal Injections Market - By End User
    • 1.3.4 Global Intradermal Injections Market - By Geography

2. Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Intradermal Injections Market Landscape

  • 4.1 Overview
  • 4.2 PEST ANALYSIS
    • 4.2.1 North America - PEST Analysis
    • 4.2.2 Europe - PEST Analysis
    • 4.2.3 Asia-Pacific - PEST Analysis
    • 4.2.4 Middle East and Africa - PEST Analysis
    • 4.2.5 South and Central America - PEST Analysis
  • 4.3 EXPERT OPINIONS

5. Intradermal Injections Market - Key Market Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Increasing Intradermal Vaccination
    • 5.1.2 Increasing Incidences of diseases
    • 5.1.3 Rising Acceptance of Aesthetic Procedures
  • 5.2 Key Market Restraints
    • 5.2.1 Risks, Complications, and Dosing Limitations Associated with Intradermal Injections
  • 5.3 Key Market Opportunities
    • 5.3.1 Significant Growth Opportunities in Developed as Well As Developing Countries
  • 5.4 Future Trends
    • 5.4.1 Strategic Developments by Manufacturers
  • 5.5 Impact Analysis of Drivers And Restraints

6. Intradermal Injections Market- Global Analysis

  • 6.1 Global Intradermal Injections Market Revenue Forecast and Analysis
  • 6.2 Global Intradermal Injections Market, By Geography - Forecast and Analysis
  • 6.3 Market Positioning of Key Players

7. Global Intradermal Injections Market Revenue And Forecasts To 2028- By Method

  • 7.1 Overview
  • 7.2 Global Intradermal Injections Market, By Method, 2021 & 2028 (%)
  • 7.3 Normal-Sized Needles (MANTOUX)
    • 7.3.1 Overview
    • 7.3.2 Normal-Sized Needles (Mantoux): Intradermal Injection Market Revenue and Forecasts To 2028 (US$ MN)
  • 7.4 Short Needles
    • 7.4.1 Overview
    • 7.4.2 Short Needles: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)
    • 7.4.3 Intradermal Microinjection
      • 7.4.3.1 Overview
      • 7.4.3.2 Intradermal Microinjection: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)
    • 7.4.4 Microneedle Arrays
      • 7.4.4.1 Overview
      • 7.4.4.2 Microneedle Arrays: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)
    • 7.4.5 Tattoo Devices
      • 7.4.5.1 Overview
      • 7.4.5.2 Tattoo Devices: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)
  • 7.5 Without Needles
    • 7.5.1 Overview
    • 7.5.2 Without Needles: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)
    • 7.5.3 Intradermal Liquid Jet Injectors
      • 7.5.3.1 Overview
      • 7.5.3.2 Intradermal Liquid Jet Injectors: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)
    • 7.5.4 Ballistic Intradermal Injectors
      • 7.5.4.1 Overview
      • 7.5.4.2 Ballistic Intradermal Injectors: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)

8. Intradermal Injections Market Revenue and Forecasts To 2028 - Application

  • 8.1 Overview
  • 8.2 Global Intradermal Injections Market Share by Application - 2021 & 2028 (%)
  • 8.3 Tuberculin Skin Testing
    • 8.3.1 Overview
    • 8.3.2 Tuberculin Skin Testing Market Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Allergy Testing
    • 8.4.1 Overview
    • 8.4.2 Allergy Testing Market Revenue and Forecast to 2028 (US$ Million)
  • 8.5 Local Aesthetics
    • 8.5.1 Overview
    • 8.5.2 Local Aesthetics Market Revenue and Forecast to 2028 (US$ Million)
  • 8.6 OTHERS
    • 8.6.1 Overview
    • 8.6.2 Others Market Forecast and Analysis

9. Intradermal Injections Market Analysis - End User

  • 9.1 Overview
  • 9.2 Global Intradermal Injections Market, By End User, 2021 & 2028 (%)
  • 9.3 Hospitals
    • 9.3.1 Overview
    • 9.3.2 Hospitals: Intradermal Injections Market Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Diagnostic Laboratories
    • 9.4.1 Overview
    • 9.4.2 Diagnostic Laboratories: Intradermal Injections Market Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Academic and Research Institutes
    • 9.5.1 Overview
    • 9.5.2 Academic and Research Institutes: Intradermal Injections Market Revenue and Forecast to 2028 (US$ Million)
  • 9.6 OTHERS
    • 9.6.1 Overview
    • 9.6.2 Others: Intradermal Injections Market Revenue and Forecast to 2028 (US$ Million)

10. Intradermal Injections Market Revenue And Forecasts To 2028 - Geographical Analysis

  • 10.1 North America: Intradermal Injections Market
    • 10.1.1 Overview
    • 10.1.2 North America: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.1.3 North America: Intradermal Injections Market, by Method, 2019-2028 (US$ Million)
      • 10.1.3.1 North America: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
      • 10.1.3.2 North America: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
    • 10.1.4 North America: Intradermal Injections Market, by Application, 2019-2028 (US$ Million)
    • 10.1.5 North America: Intradermal Injections Market, by End User, 2019-2028 (US$ Million)
    • 10.1.6 North America: Intradermal Injections Market, by Country, 2021 & 2028 (%)
      • 10.1.6.1 US: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.1.1 Overview
        • 10.1.6.1.2 US: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.1.3 US: Intradermal Injections Market, by Method, 2019-2028 (US$ Million)
        • 10.1.6.1.3.1 US: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
        • 10.1.6.1.3.2 US: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
        • 10.1.6.1.4 US: Intradermal Injections Market, by Application, 2019-2028 (US$ Million)
        • 10.1.6.1.5 US: Intradermal Injections Market, by End User, 2019-2028 (US$ Million)
      • 10.1.6.2 Canada: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.2.1 Overview
        • 10.1.6.2.2 Canada: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.2.3 Canada: Intradermal Injections Market, by Method, 2019-2028 (US$ Million)
        • 10.1.6.2.3.1 Canada: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
        • 10.1.6.2.3.2 Canada: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
        • 10.1.6.2.4 Canada: Intradermal Injections Market, by Application, 2019-2028 (US$ Million)
        • 10.1.6.2.5 Canada: Intradermal Injections Market, by End User, 2019-2028 (US$ Million)
      • 10.1.6.3 Mexico: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.3.1 Overview
        • 10.1.6.3.2 Mexico: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.3.3 Mexico: Intradermal Injections Market, by Method, 2019-2028 (US$ Million)
        • 10.1.6.3.3.1 Mexico: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
        • 10.1.6.3.3.2 Mexico: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
        • 10.1.6.3.4 Mexico: Intradermal Injections Market, by Application, 2019-2028 (US$ Million)
        • 10.1.6.3.5 Mexico: Intradermal Injections Market, by End User, 2019-2028 (US$ Million)
  • 10.2 Europe: Intradermal Injections Market
    • 10.2.1 Overview
    • 10.2.2 Europe: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.2.3 Europe: Intradermal Injections Market, by Method - Revenue and Forecast to 2028 (US$ Million)
      • 10.2.3.1 Europe: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
      • 10.2.3.2 Europe: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
    • 10.2.4 Europe: Intradermal Injections Market, by Application- Revenue and Forecast to 2028 (US$ Million)
    • 10.2.5 Europe: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
    • 10.2.6 Europe: Intradermal Injections Market, by Country, 2021 & 2028 (%)
      • 10.2.6.1 Germany: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.1.1 Overview
        • 10.2.6.1.2 Germany: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.1.3 Germany: Intradermal Injections Market, by Method - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.1.3.1 Germany: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
        • 10.2.6.1.3.2 Germany: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
        • 10.2.6.1.4 Germany: Intradermal Injections Market, by Application- Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.1.5 Germany: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.2 France: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.2.1 Overview
        • 10.2.6.2.2 France: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.2.3 France: Intradermal Injections Market, by Method - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.2.3.1 France: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
        • 10.2.6.2.3.2 France: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
        • 10.2.6.2.4 France: Intradermal Injections Market, by Application- Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.2.5 France: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.3 UK: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.3.1 Overview
        • 10.2.6.3.2 UK: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.3.3 UK: Intradermal Injections Market, by Method - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.3.3.1 UK: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
        • 10.2.6.3.3.2 UK: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
        • 10.2.6.3.4 UK: Intradermal Injections Market, by Application- Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.3.5 UK: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.4 Italy: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.4.1 Overview
        • 10.2.6.4.2 Italy: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.4.3 Italy: Intradermal Injections Market, by Method - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.4.3.1 Italy: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
        • 10.2.6.4.3.2 Italy: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
        • 10.2.6.4.4 Italy: Intradermal Injections Market, by Application- Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.4.5 Italy: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.5 Spain: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.5.1 Overview
        • 10.2.6.5.2 Spain: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.5.3 Spain: Intradermal Injections Market, by Method - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.5.3.1 Spain: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
        • 10.2.6.5.3.2 Spain: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
        • 10.2.6.5.4 Spain: Intradermal Injections Market, by Application- Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.5.5 Spain: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.6 Rest of Europe: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.6.1 Overview
        • 10.2.6.6.2 Rest of Europe: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.6.3 Rest of Europe: Intradermal Injections Market, by Method - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.6.3.1 Rest of Europe: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
        • 10.2.6.6.3.2 Rest of Europe: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
        • 10.2.6.6.4 Rest of Europe: Intradermal Injections Market, by Application- Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.6.5 Rest of Europe: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • 10.3 Asia Pacific Intradermal Injections Market Revenue and Forecasts To 2028
    • 10.3.1 Overview
    • 10.3.2 Asia Pacific Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
    • 10.3.3 Asia Pacific: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
      • 10.3.3.1 Asia Pacific: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
      • 10.3.3.2 Asia Pacific: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
    • 10.3.4 Asia Pacific: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
    • 10.3.5 Asia Pacific: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
    • 10.3.6 Asia Pacific: Intradermal Injections Market Revenue and Forecasts to 2028, By Country (%)
      • 10.3.6.1 Japan: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.3.6.1.1 Overview
        • 10.3.6.1.2 Japan: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.3.6.1.3 Japan: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
        • 10.3.6.1.3.1 Japan: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
        • 10.3.6.1.3.2 Japan: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
        • 10.3.6.1.4 Japan: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
        • 10.3.6.1.5 Japan: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 10.3.6.2 China: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.3.6.2.1 Overview
        • 10.3.6.2.2 China: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.3.6.2.3 China: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
        • 10.3.6.2.3.1 China: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
        • 10.3.6.2.3.2 China: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
        • 10.3.6.2.4 China: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
        • 10.3.6.2.5 China: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 10.3.6.3 India Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.3.6.3.1 Overview
        • 10.3.6.3.2 India: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.3.6.3.3 India: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
        • 10.3.6.3.3.1 India: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
        • 10.3.6.3.3.2 India: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
        • 10.3.6.3.4 India: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
        • 10.3.6.3.5 India: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 10.3.6.4 South Korea: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.3.6.4.1 Overview
        • 10.3.6.4.2 South Korea: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.3.6.4.3 South Korea: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
        • 10.3.6.4.3.1 South Korea: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
        • 10.3.6.4.3.2 South Korea: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
        • 10.3.6.4.4 South Korea: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
        • 10.3.6.4.5 South Korea: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 10.3.6.5 Australia: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.3.6.5.1 Overview
        • 10.3.6.5.2 Australia: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.3.6.5.3 Australia: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
        • 10.3.6.5.3.1 Australia: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
        • 10.3.6.5.3.2 Australia: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
        • 10.3.6.5.4 Australia: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
        • 10.3.6.5.5 Australia: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 10.3.6.6 Rest of Asia Pacific: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.6.1 Overview
        • 10.3.6.6.2 Rest of Asia Pacific: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.6.3 Rest of Asia Pacific: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
        • 10.3.6.6.3.1 Rest of Asia Pacific: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
        • 10.3.6.6.3.2 Rest of Asia Pacific: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
        • 10.3.6.6.4 Rest of Asia Pacific: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
        • 10.3.6.6.5 Rest of Asia Pacific: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • 10.4 Middle East & Africa Intradermal Injections Market Revenue and Forecasts To 2028
    • 10.4.1 Overview
    • 10.4.2 Middle East & Africa Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
    • 10.4.3 Middle East & Africa: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
      • 10.4.3.1 Middle East & Africa: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
      • 10.4.3.2 Middle East & Africa: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
    • 10.4.4 Middle East & Africa: Intradermal Injection Market Revenue and Forecasts to 2028, By Application (US$ Million)
    • 10.4.5 Middle East & Africa: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
    • 10.4.6 Middle East & Africa Intradermal Injections Market Revenue and Forecasts to 2028, By Country (%)
      • 10.4.6.1 UAE: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.4.6.1.1 Overview
        • 10.4.6.1.2 UAE: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.4.6.1.3 UAE: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
        • 10.4.6.1.3.1 UAE: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
        • 10.4.6.1.3.2 UAE: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
        • 10.4.6.1.4 UAE: Intradermal Injections Market Revenue and Forecasts To 2028, By Application (US$ Million)
        • 10.4.6.1.5 UAE: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 10.4.6.2 Saudi Arabia: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.4.6.2.1 Overview
        • 10.4.6.2.2 Saudi Arabia: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.4.6.2.3 Saudi Arabia: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
        • 10.4.6.2.3.1 Saudi Arabia: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
        • 10.4.6.2.3.2 Saudi Arabia: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
        • 10.4.6.2.4 Saudi Arabia: Intradermal Injections Market Revenue and Forecasts To 2028, By Application (US$ Million)
        • 10.4.6.2.5 Saudi Arabia: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 10.4.6.3 South Africa: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.4.6.3.1 Overview
        • 10.4.6.3.2 South Africa Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.4.6.3.3 South Africa: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
        • 10.4.6.3.3.1 South Africa: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
        • 10.4.6.3.3.2 South Africa: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
        • 10.4.6.3.4 South Africa: Intradermal Injections Market Revenue and Forecasts To 2028, By Application (US$ Million)
        • 10.4.6.3.5 South Africa: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 10.4.6.4 Rest of Middle East and Africa: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.4.6.4.1 Overview
        • 10.4.6.4.2 Rest of Middle East and Africa: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.4.6.4.3 Rest of Middle East & Africa: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
        • 10.4.6.4.3.1 Rest of Middle East & Africa: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
        • 10.4.6.4.3.2 Rest of Middle East & Africa: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
        • 10.4.6.4.4 Rest of Middle East & Africa: Intradermal Injections Market Revenue and Forecasts To 2028, By Application (US$ Million)
        • 10.4.6.4.5 Rest of Middle East and Africa: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • 10.5 South And Central America Intradermal Injections Market Revenue and Forecasts To 2028
    • 10.5.1 Overview
    • 10.5.2 South and Central America Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
    • 10.5.3 South and Central America Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
      • 10.5.3.1 South and Central America: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
      • 10.5.3.2 South and Central America: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
    • 10.5.4 South and Central America: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
    • 10.5.5 South and Central America: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
    • 10.5.6 South and Central America Intradermal Injections Market Revenue and Forecasts to 2028, By Country (%)
      • 10.5.6.1 Argentina Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.5.6.1.1 Overview
        • 10.5.6.1.2 Argentina Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.5.6.1.3 Argentina: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
        • 10.5.6.1.3.1 Argentina: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
        • 10.5.6.1.3.2 Argentina: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
        • 10.5.6.1.4 Argentina: Intradermal Injections Market Revenue and Forecasts To 2028, By Application (US$ Million)
        • 10.5.6.1.5 Argentina: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 10.5.6.2 Brazil: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.5.6.2.1 Overview
        • 10.5.6.2.2 Brazil: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.5.6.2.3 Brazil: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
        • 10.5.6.2.3.1 Brazil: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
        • 10.5.6.2.3.2 Brazil: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
        • 10.5.6.2.4 Brazil: Intradermal Injections Market Revenue and Forecasts To 2028, By Application (US$ Million)
        • 10.5.6.2.5 Brazil: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 10.5.6.3 Rest of South and Central America: Intradermal Injections Market- Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.3.1 Overview
        • 10.5.6.3.2 Rest of South and Central America: Intradermal Injections Market- Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.3.3 Rest of South & Central America: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
        • 10.5.6.3.3.1 Rest of South & Central America: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
        • 10.5.6.3.3.2 Rest of South & Central America: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
        • 10.5.6.3.4 Rest of South & Central America: Intradermal Injections Market Revenue and Forecasts To 2028, By Application (US$ Million)
        • 10.5.6.3.5 Rest of South and Central America: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)

11. Impact Of COVID-19 Pandemic On Intradermal Injections Market

  • 11.1 North America: Impact Assessment of COVID-19 Pandemic
  • 11.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
  • 11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
  • 11.5 South and Central America: Impact Assessment of COVID-19 Pandemic

12. Intradermal Injections Market-Industry Landscape

  • 12.1 Overview
  • 12.2 Developments
    • 12.2.1 Overview

13. Company Profiles

  • 13.1 BD
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 West Pharmaceutical Services, Inc.
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Terumo Corporation
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 NanoPass
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Pharmajet
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Idevax
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 EUNSUNG GLOBAL
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Crossject
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Cardinal Health Inc.
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Hindustan Syringes and Medical Devices Ltd
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. North America Intradermal Injections Market, by Method - Revenue and Forecast to 2028 (US$ Million)
  • Table 2. North America: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 3. North America: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. North America Intradermal Injections Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 5. North America Intradermal Injections Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 6. US Intradermal Injections Market, by Method - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. US: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. US: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 9. US Intradermal Injections Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 10. US Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 11. Canada: Intradermal Injections Market, by Method - Revenue and Forecast to 2028 (US$ Million)
  • Table 12. Canada: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. Canada: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 14. Canada Intradermal Injections Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 15. Canada Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 16. Mexico: Intradermal Injections Market, by Method - Revenue and Forecast to 2028 (US$ Million)
  • Table 17. Mexico: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 18. Mexico: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 19. Mexico Intradermal Injections Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 20. Mexico Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 21. Europe: Intradermal Injections Market, by Method - Revenue and Forecast to 2028 (US$ Million)
  • Table 22. Europe: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 23. Europe: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 24. Europe: Intradermal Injections Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 25. Europe: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 26. Germany: Intradermal Injections Market, by Method - Revenue and Forecast to 2028 (US$ Million)
  • Table 27. Germany: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 28. Germany: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 29. Germany: Intradermal Injections Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 30. Germany: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 31. France: Intradermal Injections Market, by Method - Revenue and Forecast to 2028 (US$ Million)
  • Table 32. France: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 33. France: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 34. France: Intradermal Injections Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 35. France: Intradermal Injections Market
  • Table 36. France: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 37. UK: Intradermal Injections Market, by Method - Revenue and Forecast to 2028 (US$ Million)
  • Table 38. UK: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 39. UK: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 40. UK: Intradermal Injections Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 41. UK: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 42. Italy: Intradermal Injections Market, by Method - Revenue and Forecast to 2028 (US$ Million)
  • Table 43. Italy: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 44. Italy: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 45. Italy: Intradermal Injections Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 46. Italy: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 47. Spain: Intradermal Injections Market, by Method - Revenue and Forecast to 2028 (US$ Million)
  • Table 48. Spain: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 49. Spain: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 50. Spain: Intradermal Injections Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 51. Spain: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 52. Rest of Europe: Intradermal Injections Market, by Method - Revenue and Forecast to 2028 (US$ Million)
  • Table 53. Rest of Europe: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 54. Rest of Europe: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 55. Rest of Europe: Intradermal Injections Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 56. Rest of Europe: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 57. Asia Pacific: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million).
  • Table 58. Asia Pacific: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 59. Asia Pacific: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 60. Asia Pacific: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
  • Table 61. Asia Pacific: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 62. Japan: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 63. Japan: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 64. Japan: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 65. Japan: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
  • Table 66. Japan: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 67. China: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 68. China: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 69. China: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 70. China: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
  • Table 71. China: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 72. India: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 73. India: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 74. India: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 75. India: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
  • Table 76. India: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 77. South Korea: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 78. South Korea: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 79. South Korea: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 80. South Korea: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
  • Table 81. South Korea: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 82. Australia: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 83. Australia: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 84. Australia: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 85. Australia: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
  • Table 86. Australia: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 87. Rest of Asia Pacific: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 88. Rest of Asia Pacific: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 89. Rest of Asia Pacific: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 90. Rest of Asia Pacific: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
  • Table 91. Rest of Asia Pacific: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 92. Middle East & Africa: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 93. Middle East & Africa: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 94. Middle East & Africa: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 95. Middle East & Africa: Intradermal Injection Market Revenue and Forecasts to 2028, By Application (US$ Million)
  • Table 96. Middle East & Africa: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 97. UAE: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 98. UAE: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 99. UAE: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 100. UAE: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
  • Table 101. UAE: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 102. Saudi Arabia: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 103. Saudi Arabia: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 104. Saudi Arabia: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 105. Saudi Arabia: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
  • Table 106. Saudi Arabia: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 107. South Africa Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 108. South Africa: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 109. South Africa: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 110. South Africa: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
  • Table 111. South Africa: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 112. Rest of Middle East & Africa: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 113. Rest of Middle East & Africa: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 114. Rest of Middle East & Africa: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 115. Rest of Middle East & Africa: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
  • Table 116. Rest of Middle East and Africa: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 117. South and Central America Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 118. South and Central America: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 119. South and Central America: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 120. South and Central America: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
  • Table 121. South and Central America: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 122. Argentina: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 123. Argentina: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 124. Argentina: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 125. Argentina: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
  • Table 126. Argentina: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 127. Brazil: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 128. Brazil: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 129. Brazil: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 130. Brazil: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
  • Table 131. Brazil: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 132. Rest of South & Central America: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 133. Rest of South & Central America: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 134. Rest of South & Central America: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 135. Rest of South & Central America: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
  • Table 136. Rest of South and Central America: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 137. Developments Done by Companies
  • Table 138. Glossary of Terms

List Of Figures

  • Figure 1. Intradermal Injections Market Segmentation
  • Figure 2. Intradermal Injections Market, By Region
  • Figure 3. Global Intradermal Injections Market Overview
  • Figure 4. Normal Sized Needles Segment by Method Held Largest Share of Intradermal Injection Market
  • Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 6. Intradermal Injections Market, by Geography (US$ Million)
  • Figure 7. Global Intradermal Injections Market- Leading Country Markets (US$ Million)
  • Figure 8. North America PEST Analysis
  • Figure 9. Europe PEST Analysis
  • Figure 10. Asia-Pacific PEST Analysis
  • Figure 11. Middle East and Africa PEST Analysis
  • Figure 12. South and Central America PEST Analysis
  • Figure 13. Intradermal Injection Market Impact Analysis of Drivers and Restraints
  • Figure 14. Global Intradermal Injections Market- Revenue Forecast and Analysis - 2021 - 2028
  • Figure 15. Global Intradermal Injections Market - Revenue Forecast and Analysis - 2020- 2028
  • Figure 16. Market Positioning of Key Players in Global Intradermal Injections Market
  • Figure 17. Global Intradermal Injections Market, by Method, 2021 & 2028 (%)
  • Figure 18. Normal-Sized Needles (Mantoux): Intradermal Injection Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 19. Short Needles: Intradermal Injection Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 20. Intradermal Microinjection: Intradermal Injection Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 21. Microneedle Arrays: Intradermal Injection Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 22. Tattoo Devices: Intradermal Injection Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 23. Without Needle: Intradermal Injection Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 24. Intradermal Liquid Jet Injectors: Intradermal Injection Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 25. Ballistic Intradermal Injectors: Intradermal Injection Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 26. Global Intradermal Injections Market Share by Application - 2021 & 2028 (%)
  • Figure 27. Tuberculin Skin Test Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 28. Allergy Testing Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 29. Local Aesthetic Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 30. Others Intradermal Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 31. Global Intradermal Injections Market, by End User, 2021 & 2028 (%)
  • Figure 32. Hospital : Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 33. Diagnostic Laboratories : Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 34. Academic & Research Institutes : Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 35. Others: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 36. North America: Intradermal Injections Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 37. North America Intradermal Injections Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 38. North America: Intradermal Injections Market, by Country, 2021 & 2028 (%)
  • Figure 39. US: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 40. Canada: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 41. Mexico: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 42. Europe: Intradermal Injections Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 43. Europe: Intradermal Injections Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 44. Europe: Intradermal Injections Market, by Country, 2021 & 2028 (%)
  • Figure 45. Germany: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 46. France: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 47. UK: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 48. Italy: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 49. Spain: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 50. Rest of Europe: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 51. Asia Pacific Intradermal Injections Market Overview, by Country (2021)
  • Figure 52. Asia Pacific: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 53. Asia Pacific: Intradermal Injections Market Revenue and Forecasts to 2028, By Country (%)
  • Figure 54. Japan: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 55. China: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 56. India: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 57. South Korea: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 58. Australia: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 59. Rest of Asia Pacific: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 60. Middle East & Africa Intradermal Injections Market Revenue Overview, by Country, 2021 (US$ Million)
  • Figure 61. Middle East & Africa Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 62. Middle East & Africa Intradermal Injections Market Revenue and Forecasts to 2028, By Country (%)
  • Figure 63. UAE: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 64. Saudi Arabia: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 65. South Africa: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 66. Rest of Middle East and Africa: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 67. South and Central America Intradermal Injections Market Revenue Overview, by Country, 2021 (US$ Million)
  • Figure 68. South and Central America Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 69. South and Central America Intradermal Injections Market Revenue and Forecasts to 2028, By Country (%)
  • Figure 70. Argentina Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 71. Brazil: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 72. Rest of South and Central America: Intradermal Injections Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 73. Impact of COVID-19 Pandemic in North American Country Markets
  • Figure 74. Impact of COVID-19 Pandemic in European Country Markets
  • Figure 75. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
  • Figure 76. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
  • Figure 77. Impact Of COVID-19 Pandemic in South and Central America Africa Country Markets